Documentation: Review the current product specification and batch-level COA where available
No significant association between other GLP-1 RAs and suicidality was observed. Association of Glucagon-Like Peptide-1 Receptor Agonist Use With Risk of Psychiatric Disorders: A Systematic Review and Meta-Analysis of Randomised Controlled Trials 2026: GLP-1 RAs use was not associated with the risk of psychiatric disorders, including depression, suicide or anxiety. Association of glucagon-like peptide-1 receptor agonist use with anxiety disorders, depression, self-harm, and suicidality: a large cohort study 2026: GLP-1 RAs were associated with a higher risk of anxiety disorders and depression, but no difference in suicidality or self-harm in comparison to SGLT2i, DPP4i, and lower suicidality risk compared to SU. The effect of glucagon-like Peptide-1 receptor agonists on measures of suicidality: A systematic review 2025: suicide ideation (SI) [] Pharmacovigilance studies indicate that semaglutide and liraglutide are associated with disproportionate reporting of SI
Our company was established in the year 2010
Each needle is 0.27mm long
Alpha BioMeds 4X Blend brings four research peptides into a single formulationGHRP-2, Tesamorelin, MGF, and Ipamorelinto support studies where multi-pathway activation is preferred
Research vendors describe themselves as chemical suppliers rather than compounding pharmacies under FDA sections 503A and 503B
